Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Matthijs van der Laan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Performance of a Personalized Smart Cueing Device to Detect Freezing of Gait in Parkinson's Disease

    by Matthijs van der Laan, Erwin E. H. van Wegen, Jens A. N. Keijser, Sander A. L. M. Minnoye, Rein van Zutven, Vincent de Groot, Marc B. Rietberg, Jorik Nonnekes

    External cueing is a proven strategy to overcome freezing of gait (FoG) in Parkinson's disease (PD). However, manual activation of cueing is often too late and continuous cueing may be perceived as burdensome. Therefore, the Cue2walk, a medical device for FoG detection and provision of external cues, was developed. This study aimed to determine (1) the performance to detect FoG of the Cue2walk device and (2) the effect of personal optimization on its performance to detect FoG. Twenty‐four people with PD and daily FoG completed a gait circuit including FoG‐triggering tasks in their own home environment, while wearing a Cue2walk device to collect acceleration data. Two experienced independent raters rated the occurrence of FoG using video annotation. The data set of each participant was split into a training (60%) and test set (40%), obtaining an even distribution of FoG episodes. The training set was used to personalize the settings of the algorithm. The test set was subsequently used to assess the performance to detect FoG of the standard and personalized setting by calculating sensitivity, specificity, and latency (time between onset and detection of FoG). Sensitivity was 28.2% ± 31.6%, specificity was 96.0% ± 4.1%, and latency was 1.9 s ± 2.4 s on the test set with the standard settings. With personalized settings, sensitivity was 89.1% ± 14.8%, specificity was 93.3% ± 5.5%, and latency was 1.6 s ± 2.2 s. Sensitivity was significantly higher for the personalized settings ( p < 0.001), while latency and specificity remained similar. The Cue2walk device showed good performance to detect FoG when using the personalized settings. The clinical effectiveness needs to be determined in future research.

  • Open Access

    User Experiences of the Cue2walk Smart Cueing Device for Freezing of Gait in People with Parkinson’s Disease

    by Matthijs van der Laan, Marc B. Rietberg, Martijn van der Ent, Floor Waardenburg, Vincent de Groot, Jorik Nonnekes, Erwin E. H. van Wegen

    Freezing of gait (FoG) impairs mobility and daily functioning and increases the risk of falls, leading to a reduced quality of life (QoL) in people with Parkinson’s disease (PD). The Cue2walk, a wearable smart cueing device, can detect FoG and hereupon provides rhythmic cues to help people with PD manage FoG in daily life. This study investigated the user experiences and device usage of the Cue2walk, and its impact on health-related QoL, FoG and daily activities. Twenty-five users of the Cue2walk were invited to fill out an online survey, which included a modified version of the EQ-5D-5L, tailored to the use of the Cue2walk, and its scale for health-related QoL, three FoG-related questions, and a question about customer satisfaction. Sixteen users of the Cue2walk completed the survey. Average device usage per day was 9 h (SD 4). Health-related QoL significantly increased from 5.2/10 (SD 1.3) to 6.2/10 (SD 1.3) (p = 0.005), with a large effect size (Cohen’s d = 0.83). A total of 13/16 respondents reported a positive effect on FoG duration, 12/16 on falls, and 10/16 on daily activities and self-confidence. Customer satisfaction was 7.8/10 (SD 1.7). This pilot study showed that Cue2walk usage per day is high and that 15/16 respondents experienced a variety of positive effects since using the device. To validate these findings, future studies should include a larger sample size and a more extensive set of questionnaires and physical measurements monitored over time.


  • Open Access

    Skeletal muscle mitochondrial health in type 1 diabetes: the role of exercise capacity and lifestyle factors

    by Richie P. Goulding, Braeden T. Charlton, Ellen A. Breedveld, Jelle Y. Huijts, Matthijs van der Laan, Anne R. Strating, Wendy Noort, Aryna Kolodyazhna, Anita E. Grootemaat, Frank W. Bloemers, et al.

    Aims/hypothesis: Previous studies reporting lower skeletal muscle mitochondrial function in type 1 diabetes did not account for cardiorespiratory fitness, a key confounder when assessing mitochondrial function. We hypothesised that, compared with healthy individuals, muscle mitochondrial phenotypic differences would be abolished in individuals with type 1 diabetes when matched for age, sex, BMI and maximal oxygen uptake ( $$\dot{V}{\text{O}}_{\text{2max}}$$ V ˙ O 2max ). Methods: Seventeen individuals with type 1 diabetes and seventeen healthy control individuals matched for age, sex, BMI and $$\dot{V}{\text{O}}_{\text{2max}}$$ V ˙ O 2max participated and underwent a muscle biopsy from the vastus lateralis. Mitochondrial respiration was assessed by high-resolution respirometry, and mitochondrial density and morphology were assessed by transmission electron microscopy. Results: $$\dot{V}{\text{O}}_{\text{2max}}$$ V ˙ O 2max (individuals with type 1 diabetes 40±10 kg−1 min−1; control individuals 41±8 ml kg−1 min−1; p=0.51) and mitochondrial oxidative phosphorylation capacity (individuals with type 1 diabetes 101±35 [pmol O2] s−1 mg−1; control individuals 99±23 [pmol O2] s−1 mg−1, p=0.82) did not differ between groups. Both intermyofibrillar (individuals with type 1 diabetes 6.07±2.16%; control individuals 6.01±1.11%; p=0.92) and subsarcolemmal (individuals with type 1 diabetes 18.70±8.16%; control individuals 19.29±7.36%; p=0.83) mitochondrial densities were not different between groups. Mitochondrial respiration normalised by density did not differ between groups. However, individuals with type 1 diabetes and higher HbA1c displayed lower rates of mitochondrial respiration than those with lower HbA1c, whereas those with higher BMI displayed lower mitochondrial densities than those with lower BMI. Conclusions/interpretation: Collectively, our study demonstrates that when matched for age, sex, BMI and $$\dot{V}{\text{O}}_{\text{2max}}$$ V ˙ O 2max , maximal muscle mitochondrial respiration and morphology in people with type 1 diabetes are not impaired. These findings highlight the importance of habitual exercise, optimal glucose management and a healthy BMI in maintaining mitochondrial health in individuals with type 1 diabetes. Graphical


  • Open Access

    Featured Cover

    by Richie P. Goulding, Braeden T. Charlton, Ellen A. Breedveld, Matthijs van der Laan, Anne R. Strating, Wendy Noort, Aryna Kolodyazhna, Brent Appelman, Michèle van Vugt, Anita E. Grootemaat, et al.

    Cover legend: The cover image is based on the article Skeletal muscle mitochondrial fragmentation predicts age‐associated decline in physical capacity by Rob Wüst et al., https://doi.org/10.1111/acel.14386.

  • Open Access

    Skeletal muscle mitochondrial fragmentation predicts age‐associated decline in physical capacity

    by Richie P. Goulding, Braeden T. Charlton, Ellen A. Breedveld, Matthijs van der Laan, Anne R. Strating, Wendy Noort, Aryna Kolodyazhna, Brent Appelman, Michèle van Vugt, Anita E. Grootemaat, et al.

    Ageing substantially impairs skeletal muscle metabolic and physical function. Skeletal muscle mitochondrial health is also impaired with ageing, but the role of skeletal muscle mitochondrial fragmentation in age‐related functional decline remains imprecisely characterized. Here, using a cross‐sectional study design, we performed a detailed comparison of skeletal muscle mitochondrial characteristics in relation to in vivo markers of exercise capacity between young and middle‐aged individuals. Despite similar overall oxidative phosphorylation capacity (young: 99 ± 17 vs. middle‐aged: 99 ± 27 pmol O2.s−1.mg−1, p = 0.95) and intermyofibrillar mitochondrial density (young: 5.86 ± 0.57 vs. middle‐aged: 5.68 ± 1.48%, p = 0.25), older participants displayed a more fragmented intermyofibrillar mitochondrial network (young: 1.15 ± 0.17 vs. middle‐aged: 1.55 ± 0.15 A.U., p < 0.0001), a lower mitochondrial cristae density (young: 23.40 ± 7.12 vs. middle‐aged: 13.55 ± 4.10%, p = 0.002) and a reduced subsarcolemmal mitochondrial density (young: 22.39 ± 6.50 vs. middle‐aged: 13.92 ± 4.95%, p = 0.005). Linear regression analysis showed that 87% of the variance associated with maximal oxygen uptake could be explained by skeletal muscle mitochondrial fragmentation and cristae density alone, whereas subsarcolemmal mitochondrial density was positively associated with the capacity for oxygen extraction during exercise. Intramuscular lipid accumulation was positively associated with mitochondrial fragmentation and negatively associated with cristae density. Collectively, our work highlights the critical role of skeletal muscle mitochondria in age‐associated declines in physical function.